Postprandial Hypertriglyceridemia and Cardiovascular Disease: Current and Future Therapies
出版年份 2013 全文链接
标题
Postprandial Hypertriglyceridemia and Cardiovascular Disease: Current and Future Therapies
作者
关键词
Postprandial dyslipoproteinemia, Triglyceride-rich lipoprotein, Cardiovascular disease
出版物
Current Atherosclerosis Reports
Volume 15, Issue 3, Pages -
出版商
Springer Nature
发表日期
2013-01-23
DOI
10.1007/s11883-013-0309-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance
- (2012) Mark Naples et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans
- (2012) Changting Xiao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
- (2012) Evan A. Stein et al. CIRCULATION
- The Complex Genetic Basis of Plasma Triglycerides
- (2012) Christopher T. Johansen et al. Current Atherosclerosis Reports
- Antisense oligonucleotides for the treatment of dyslipidaemia
- (2012) Maartje E. Visser et al. EUROPEAN HEART JOURNAL
- The DGAT1 Inhibitor LCQ908 Decreases Triglyceride Levels in Patients with the Familial Chylomicronemia Syndrome
- (2012) Charles Meyers et al. Journal of Clinical Lipidology
- Mutations inLPL,APOC2,APOA5,GPIHBP1andLMF1in patients with severe hypertriglyceridaemia
- (2012) R. P. Surendran et al. JOURNAL OF INTERNAL MEDICINE
- Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
- (2012) Jeremy D. Furtado et al. JOURNAL OF LIPID RESEARCH
- Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects
- (2012) Esther M. M. Ooi et al. JOURNAL OF LIPID RESEARCH
- AN ANTISENSE INHIBITOR OF APOLIPOPROTEIN C-III LOWERS FASTING PLASMA APOLIPOPROTEIN C-III AND TRIGLYCERIDE CONCENTRATIONS IN HEALTHY VOLUNTEERS
- (2012) Vickie Alexander et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- The chronic effects of fish oil with exercise on postprandial lipaemia and chylomicron homeostasis in insulin resistant viscerally obese men
- (2012) Karin M Slivkoff-Clark et al. Nutrition & Metabolism
- Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
- (2011) Lutgarda Bozzetto et al. ATHEROSCLEROSIS
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states
- (2011) Sarah Farr et al. CURRENT OPINION IN LIPIDOLOGY
- Clinical Relevance of Non-Fasting and Postprandial Hypertriglyceridemia and Remnant Cholesterol
- (2011) Borge G. Nordestgaard et al. Current Vascular Pharmacology
- Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
- (2010) Eric A. Schwartz et al. ATHEROSCLEROSIS
- Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
- (2010) D. C. Chan et al. DIABETES CARE
- Genetic determinants of plasma triglycerides
- (2010) Christopher T. Johansen et al. JOURNAL OF LIPID RESEARCH
- Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy
- (2010) Fatima Akdim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults
- (2009) Earl S. Ford et al. ARCHIVES OF INTERNAL MEDICINE
- Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk
- (2009) J. W. Su et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
- (2009) D. Masuda et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia
- (2009) André J Tremblay et al. JOURNAL OF LIPID RESEARCH
- Therapeutic Effects of Fibrates in Postprandial Lipemia
- (2008) Genovefa D Kolovou et al. American Journal of Cardiovascular Drugs
- Leukocyte Activation by Triglyceride-Rich Lipoproteins
- (2008) Arash Alipour et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins
- (2008) Stefania Lamon-Fava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients
- (2008) Gideon R. Hajer et al. ATHEROSCLEROSIS
- Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome
- (2008) D. C. Chan et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
- (2008) D. C. Chan et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials
- (2008) A. Pandor et al. JOURNAL OF INTERNAL MEDICINE
- Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender
- (2008) Estibaliz Olano-Martin et al. JOURNAL OF LIPID RESEARCH
- Thematic Review Series: Glycerolipids.DGAT enzymes and triacylglycerol biosynthesis
- (2008) Chi-Liang Eric Yen et al. JOURNAL OF LIPID RESEARCH
- Aerobic Exercise and Postprandial Lipemia in Men with the Metabolic Syndrome
- (2008) MICHAEL L. MESTEK et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia
- (2008) Jean-Charles Hogue et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started